Shape Therapeutics’ Big Financing Shows Growing Interest In Novel Capsids

 
• By Alaric DeArment

Several companies have recently raised large amounts of money from venture capital as well as potentially through partnerships for next-generation capsid technology.

Horizontal image of a collection of prescription capsules and tablets in the shape of DNA running diagonally across the picture on a light green background with room for copy (text).
Shape Therapeutics said it raised $116m in a series B venture capital round • Source: Shutterstock

More from Financing

More from Business